Ascendis Pharma A/S (ASND)
NASDAQ
Closed
Oct 6, 2026
Day's Range
222.7252 wk Range
186.05Overview - ASND - Ascendis Pharma A/S
Key Statistics
Valuation
Enterprise Value
16.36B
P/E (Trailing)
‪17.71‬
P/E (Forward)
‪20.84‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪14.28‬
Price / Book
‪9.16‬
EV / EBITDA
‪55.28‬
Profitability
Gross Margin
‪91.84%‬
Profit Margin
‪70.84%‬
Operating Margin
‪64.97%‬
Return on Assets
‪9.58%‬
Return on Equity
‪118.78%‬
Ownership
Shares Outstanding
65.67M
Float
65.64M
Short % of Shares Outstanding
‪7.13%‬
Held by Insiders
‪0.77%‬
Held by Institutions
‪104.04%‬
Price stats
50-Day Avg
‪249.69‬
200-Day Avg
‪235.46‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
20 analysts
Average price target
‪$ 313.40‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ASND - Ascendis Pharma A/S
Peers - ASND - Ascendis Pharma A/S
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ASNDNASDAQAscendis Pharma A/S14.99BMarket Cap+7.48%52-week change17.72P/E (Trailing)‪70.84%‬Profit Margin
- ARGXNASDAQArgenx SE57.50BMarket Cap+14.28%52-week change34.96P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.40BMarket Cap-105.72%52-week change38.35P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share24.34BMarket Cap-8.52%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.14BMarket Cap+18.80%52-week change-17.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.11.06BMarket Cap+2.75%52-week change154.54P/E (Trailing)‪2.14%‬Profit Margin
- AXSMNASDAQAxsome Therapeutics Inc.9.37BMarket Cap+33.09%52-week change-48.69P/E (Trailing)‪-24.67%‬Profit Margin
Profile Summary - ASND - Ascendis Pharma A/S
About
Ascendis Pharma A/S is a global biopharmaceutical company focused on developing and commercializing therapies for rare endocrine diseases and other serious chronic conditions. The company uses its proprietary TransCon technology platform to create medicines designed to improve treatment delivery and address unmet…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
